A multi-centre, randomised, double-blind, placebo-controlled clinical trial examining the efficacy and safety of low-dose aspirin after initial anticoagulation to prevent recurrent venous thromboembolism (ASPIRE)

Auteurs
Catégorie Primary study
Registry of TrialsANZCTR
Year 2005

Cet article est inclus dans 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ASPIRE [Aspirin to Prevent Recurrent Venous Thromboembolism] (4 documents)
Loading references information
Cet article n'a pas de résumé
Epistemonikos ID: a125dec49b17464900d955b548562507c262efe7
First added on: Apr 23, 2018